Patent Number: 8,586,005

Title: Ultrasound contrast agent dosage formulation

Abstract: Clinical studies have been conducted and specific dosage formulations developed using polymeric microparticles having incorporated therein perfluorocarbon gases that provide significantly enhanced images of long duration. The dosage formulation includes microparticles formed of a biocompatible polymer, preferably including a lipid incorporated therein, and containing a perfluorocarbon that is a gas at body temperature. The microparticles are provided to a patient in an amount effective to enhance ultrasound imaging in the ventricular chambers for more than 5 minutes or in the mycocardium for more than a minute, in a dose ranging from 0.025 to 8.0 mg microparticles/kg body weight. Preferably the dose ranges from 0.05 to 4.0 mg microparticles/kg body weight. The dosage formulation typically is provided in a vial. A typical formulation is in the form of a dry powder that is reconstituted with sterile water prior to use by adding the water to the vial or syringe of the dry powder and shaking to yield an isosmotic or isotonic suspension of microparticles.

Inventors: Walovitch; Richard (Framingham, MA), Bernstein; Howard (Cambridge, MA), Chickering, III; Donald (Framingham, MA), Straub; Julie (Winchester, MA)

Assignee: Acusphere, Inc.

International Classification: A61B 8/00 (20060101); A61K 49/00 (20060101)

Expiration Date: 1/19/12018